Laurion Capital Management LP Ironwood Pharmaceuticals Inc Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$5.58 - $8.61 $93,972 - $145,001
16,841 New
16,841 $109,000
Q3 2020

Nov 13, 2020
SELL
$8.99 - $10.74 $364,220 - $435,120
-40,514 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$9.14 - $11.97 $370,297 - $484,952
40,514 New
40,514 $418,000
Q2 2019

Aug 13, 2019
SELL
$9.8 - $12.89 $1.26 Million - $1.66 Million
-128,940 Closed
0 $0
Q1 2019

May 08, 2019
BUY
$8.27 - $12.73 $1.07 Million - $1.64 Million
128,940 New
128,940 $1.75 Million

Others Institutions Holding IRWD

# of Institutions
238
Shares Held
162M
Call Options Held
11.2M
Put Options Held
9.1K
View Full List

About IRONWOOD PHARMACEUTICALS INC

IRWD Quotes by TradingView
  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email